Clinical Trials Logo

Filter by:
NCT ID: NCT02666794 Completed - Catecholamines Clinical Trials

Plasmatic Catecholamines: Randomized Controlled Trial Comparing Epidural Versus Combined Spinal-epidural

Start date: July 12, 2017
Phase: N/A
Study type: Interventional

Combined spinal-epidural (CSE) for labor analgesia has been associated with fetal bradycardia and uterine hypertonia, possibly due to asymmetric decrease in catecholamine levels, when compared with epidural analgesia (EP).

NCT ID: NCT02665546 Completed - Clinical trials for Langerhans Cell Histiocytosis

Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis

Start date: March 2016
Phase:
Study type: Observational

Pulmonary Langerhans Histiocytosis Cells (PLCH) is characterized by infiltration of Langerhans cells and formation of loose granulomas with lymphocytic infiltrate and formation of nodular and cystic lesions on chest CT, and is often associated with smoking. Functionally, there may be obstructive and / or restrictive defect, with reduced carbon monoxide diffusing capacity. Dyspnea and lower exercise tolerance are common in PLCH, but exercise capacity in this disease is poorly understood and has not been compared to controls. Besides, the mechanisms involved in limiting exercise are poorly understood and cover multiple factors such as change in gas exchange, pulmonary hypertension (PH), dynamic hyperinflation, physical deconditioning and left heart failure. The involvement of pulmonary circulation in PLCH has unknown prevalence, but contributes to the symptoms. In the PH classification, PLCH belongs to the group 5, of multifactorial etiology. The definition of the presence and contribution of dyspnea mechanisms in different severities of PLCH is important to understanding the disease and individualization of treatment. The objective of the study is to evaluate the exercise capacity of patients with HCLP, and determinate mechanisms of dyspnea and lower exercise tolerance beyond its impact on quality of life.

NCT ID: NCT02665533 Completed - Pain Clinical Trials

Evaluation of Two Pharmacological Protocols for Pre-emptive Analgesia in Impacted Third Molar Surgery

Start date: January 2016
Phase: N/A
Study type: Interventional

The main aim of the study is to investigate the pre-emptive effect of dexamethasone and diclofenac associated to codeine to prevent the pain, edema and limited mouth opening at the extraction of third molar.

NCT ID: NCT02664792 Completed - Clinical trials for Non-small Cell Lung Carcinoma

Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer

Start date: August 2014
Phase: N/A
Study type: Interventional

To evaluate the diagnostic accuracy of the 18Fluor-fluorodeoxyglucose ([18F]FDG) in the Positron Emission Tomography/Computed Tomography (PET/CT) as compared to mediastinoscopy for staging of non-small cel lung carcinoma.

NCT ID: NCT02663973 Completed - Breast Cancer Clinical Trials

Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III

Start date: January 1, 2016
Phase:
Study type: Observational

The principal goal of this study is to describe the epidemiology of breast cancer in the Brazilian population

NCT ID: NCT02662868 Completed - Clinical trials for Metastatic Breast Cancer

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

Start date: June 2015
Phase: N/A
Study type: Observational

The purpose of this study is to describe demographics and socioeconomics characteristics associated to the diagnosis of metastatic breast cancer in Brazil.

NCT ID: NCT02662569 Completed - Clinical trials for Diabetes, Hyperlipidemia, Mixed Dyslipidemia

Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia

BERSON
Start date: April 14, 2016
Phase: Phase 3
Study type: Interventional

The primary objective of this study was to evaluate the effect of 12 weeks of subcutaneous evolocumab (AMG 145) in combination with statin therapy (atorvastatin) on percent change from baseline in low-density lipoprotein cholesterol (LDL-C) in diabetic adults with hyperlipidemia or mixed dyslipidemia.

NCT ID: NCT02660333 Completed - Morbid Obesity Clinical Trials

Effect of Prebiotic or Synbiotic on Inflammatory Response and Indicators of Nutritional Status in Obesity

Start date: January 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of prebiotic or synbiotic supplementation on inflammatory response and indicators of nutritional status in patients with morbid obesity. Study hypothesis: Supplementation of 12 g/day of fructooligosaccharides (prebiotic) or 12 g/day of fructooligosaccharides + strains of lactobacilli and bifidobacteria (synbiotic) during 30 days promotes reduction of plasma/serum levels of acute phase proteins, cytokines, metabolic and anthropometric parameters in individuals with BMI ≥ 40kg/m².

NCT ID: NCT02659267 Completed - Healthy Clinical Trials

Evaluation of a Strategy Designed to Promote Physical and Healthy Eating

VAMOS
Start date: October 2014
Phase: N/A
Study type: Interventional

The study aims to verify if the VAMOS strategy contributes to an increase in physical activity and healthy eating habits among users of the Health Academy Program from Belo Horizonte, Minas Gerais.

NCT ID: NCT02658578 Completed - Stroke Clinical Trials

Peripheral Nerve Stimulation and Motor Training in Stroke

Start date: March 2016
Phase: N/A
Study type: Interventional

Cerebrovascular disease is a major cause of disability worldwide. The catastrophic burden of stroke is more dramatic in low- and middle- income countries, and the scarcity of evidence-based rehabilitation interventions represents a major challenge to global health care. Upper limb weakness is frequent after stroke, but there is no universally accepted treatment to effectively improve hand function in patients with moderate and severe motor impairment. These are the patients in deepest need of rehabilitative interventions. This project addresses this important issue, by testing effects of a novel approach. The investigators will non-invasively stimulate peripheral nerves in order to enhance effects of motor training aided by an electrical stimulation device in patients with moderate to severe hand weakness. Our hypothesis is that peripheral nerve stimulation will enhance effects of motor training in patients in the chronic stage after stroke.